Matthew S. Schwartz
Matthew S. Schwartz is a reporter with NPR's news desk. Before coming to NPR, Schwartz worked as a reporter for Washington, DC, member station WAMU, where he won the national Edward R. Murrow award for feature reporting in large market radio. Previously, Schwartz worked as a technology reporter covering the intricacies of Internet regulation. In a past life, Schwartz was a Washington telecom lawyer. He got his J.D. from Georgetown University Law Center, and his B.A. from the University of Michigan ("Go Blue!").
-
The U.S. and European allies are ramping up sanctions against Russia that include moving to cut off certain Russian banks from the key bank messaging system. -
Dillon Helbig wrote a book over winter break and slipped it onto a local library shelf in Boise, Idaho. After librarians found it, they entered it into their catalog. Now it's on a long waiting list. -
Is it ever justifiable to engage in violent protest against the government? Nearly a quarter of Americans responded "Yes" to that question in a survey conducted by The COVID States Project.
-
People who test positive need to isolate themselves for 5 days if they don't show symptoms. The change reflects "what we know about the spread of the virus" and vaccine protection, the CDC chief says. -
The virus is the enemy, NIH Director Francis Collins said. "It's not the other people in the other political party." Omicron, which could soon become the dominant strain, is extremely infectious. -
Military officials say that, after months of warnings, they have begun disciplinary actions. The Army has reprimanded 2,700 soldiers and said it will begin discharge proceedings in the new year. -
After recovering from wounds suffered in World War II, Dole went on to represent Kansas in Congress for more than 30 years. -
President Biden said on Sunday that the U.S. has evacuated nearly 28,000 people from Afghanistan since Aug. 14. But he said there is "no way to evacuate this many people without pain and loss." -
Regeneron's antibody cocktail, authorized by the Food and Drug Administration, treats COVID-19 symptoms in people who are at high risk of developing severe symptoms.
-
In an interview with NPR's All Things Considered, Knox talks about what it's like to be followed by fictionalized versions of her life.
